SynthesisSystematic reviews2025
Medication-related problems and contributing factors in patients with cardiovascular disorders in Ethiopia: a systematic review and meta-analysis.
Synthesis in Systematic reviews, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundCardiovascular diseases (CVDs) are a leading cause of mortality and disability globally. In Ethiopia, the management of CVDs faces significant challenges, particularly in addressing medication-related problems (MRPs). This systematic review and meta-analysis aims to assess the prevalence of MRPs among CVD patients in Ethiopia.
methodsThe review followed the PRISMA guidelines and was registered in the PROSPERO database (CRD42024501087). A comprehensive search was conducted across databases including PubMed, Hinari, Embase, and Scopus. Studies were included if they focused on the prevalence of MRPs among Ethiopian CVD patients, were observational in design, and were published in English. Quality assessment was performed using the JBI critical appraisal checklist. Data were analyzed using a weighted inverse random-effects model with subgroup analyses conducted based on various study characteristics. Heterogeneity was assessed using the I
resultsFrom 405 potential studies, 22 met the inclusion criteria, comprising 5700 patient cases and identifying 7780 MRPs. The pooled prevalence of MRPs among CVD patients in Ethiopia was 74% (95% CI 66-81, I
conclusionsThe high prevalence of MRPs among CVD patients in Ethiopia highlights the need for targeted interventions to optimize medication management and improve patient outcomes. Healthcare providers should focus on individualized care, regular medication reviews, and patient education to address these problems effectively.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.